Scott I. Merz
Founder bij Michigan Critical Care Consultants, Inc.
Profiel
Scott I.
Merz is the founder of Michigan Critical Care Consultants, Inc. founded in 1991, where he holds the titles of President, Chief Executive Officer & Director.
Currently, he is a Director at Seraph Biosciences, Inc. Dr. Merz was a Director at Cardigant Medical, Inc. from 2012 to 2014.
Dr. Merz received his undergraduate degree from Duke University and his doctorate from the University of Michigan.
Actieve functies van Scott I. Merz
| Bedrijven | Functie | Begin |
|---|---|---|
Michigan Critical Care Consultants, Inc.
 Michigan Critical Care Consultants, Inc. Medical SpecialtiesHealth Technology Michigan Critical Care Consultants, Inc. engages in the development of medical devices. The company was founded by Scott Merz and Robert Bartlett in 1991 and is headquartered in Dexter, MI. | Founder | 15-06-2011 |
Seraph Biosciences, Inc.
 Seraph Biosciences, Inc. Medical SpecialtiesHealth Technology Seraph Biosciences, Inc. develops Raman Spectroscopy that operates as a equipment for real-time pathogen detection and point of care. The company was founded by Charles Shanley, Gregor Auner, and Mark Trexler and is headquartered in Detroit, MI. | Director/Board Member | - |
Eerdere bekende functies van Scott I. Merz
| Bedrijven | Functie | Einde |
|---|---|---|
Cardigant Medical, Inc.
 Cardigant Medical, Inc. BiotechnologyHealth Technology Cardigant Medical, Inc. operates as a development stage biotechnology company. The company focuses on the development of novel biologic compounds and methods for local delivery for the treatment of cardiovascular and peripheral vascular disease. It plans to treat atherosclerosis and plaque stabilization using targeted delivery of large molecule therapeutics based on high density lipoprotein targets. The company also focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes, carotid stenosis and aortic valve stenosis. Cardigant Medical was founded on April 17, 2009 by Jerett A. Creed and is headquartered in Manhattan Beach, CA. | Director/Board Member | 22-08-2014 |
Opleiding van Scott I. Merz
| Duke University | Undergraduate Degree |
| University of Michigan | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cardigant Medical, Inc.
Cardigant Medical, Inc. BiotechnologyHealth Technology Cardigant Medical, Inc. operates as a development stage biotechnology company. The company focuses on the development of novel biologic compounds and methods for local delivery for the treatment of cardiovascular and peripheral vascular disease. It plans to treat atherosclerosis and plaque stabilization using targeted delivery of large molecule therapeutics based on high density lipoprotein targets. The company also focuses on the use of biologics and combination biologics and devices for the treatment of acute coronary syndromes, carotid stenosis and aortic valve stenosis. Cardigant Medical was founded on April 17, 2009 by Jerett A. Creed and is headquartered in Manhattan Beach, CA. | Health Technology |
Michigan Critical Care Consultants, Inc.
Michigan Critical Care Consultants, Inc. Medical SpecialtiesHealth Technology Michigan Critical Care Consultants, Inc. engages in the development of medical devices. The company was founded by Scott Merz and Robert Bartlett in 1991 and is headquartered in Dexter, MI. | Health Technology |
Seraph Biosciences, Inc.
Seraph Biosciences, Inc. Medical SpecialtiesHealth Technology Seraph Biosciences, Inc. develops Raman Spectroscopy that operates as a equipment for real-time pathogen detection and point of care. The company was founded by Charles Shanley, Gregor Auner, and Mark Trexler and is headquartered in Detroit, MI. | Health Technology |
